Investigation of the G protein subunit Gαolf gene (GNAL) in attention deficit/hyperactivity disorder

Journal of Psychiatric Research

Volumn 42, Issue 2, 2008, Pages 117-124

  Laurin, Nancy ^a   Ickowicz, Abel ^b   Pathare, Tejaswee ^b   Malone, Molly ^b   Tannock, Rosemary ^b   Schachar, Russell ^b   Kennedy, James L ^c   Barr, Cathy L ^a,b  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

Attention deficit hyperactivity disorder; Dopamine receptor D1; G protein; Genetics; G olf; Transmission disequilibrium test

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; MARKER; PROTEIN SUBUNIT;

ALLELE; ARTICLE; ATTENTION DEFICIT DISORDER; DISEASE PREDISPOSITION; FATHER; FEMALE; GENE; GENE LOCUS; GENETIC POLYMORPHISM; GENOME IMPRINTING; HUMAN; IMPULSIVENESS; INHERITANCE; INTRON; MAJOR CLINICAL STUDY; MALE; MOTHER; NUCLEAR FAMILY; PARENT; PRIORITY JOURNAL; SECONDARY ANALYSIS; SYMPTOM;

EID: 35848936058     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2006.10.010     Document Type: Article

References (70)

1. Andersen S.L., and Teicher M.H. Sex differences in dopamine receptors and their relevance to ADHD. Neuroscience and Biobehavioral Reviews 24 (2000) 137-141
2. Arnsten A.F., and Dudley A.G. Methylphenidate improves prefrontal cortical cognitive function through alpha2 adrenoceptor and dopamine D1 receptor actions: relevance to therapeutic effects in attention deficit hyperactivity disorder. Behavioral and Brain Functions 1 (2005) 2
3. Arnsten A.F., and Li B.M. Neurobiology of executive functions: catecholamine influences on prefrontal cortical functions. Biological Psychiatry 57 (2005) 1377-1384
4. Badner J.A., and Gershon E.S. Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia. Molecular Psychiatry 7 (2002) 405-411
5. Balciuniene J., Yuan Q.P., Engstrom C., Lindblad K., Nylander P.O., Sundvall M., et al. Linkage analysis of candidate loci in families with recurrent major depression. Molecular Psychiatry 3 (1998) 162-168
6. Barr C., Wigg K., and Sandor P. Catechol-O-methyltransferase and Gilles de la Tourette syndrome. Molecular Psychiatry 4 (1999) 492-495
7. Barrett J.C., Fry B., Maller J., and Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21 (2005) 263-265
8. Bayer L.E., Brown A., Mactutus C.F., Booze R.M., and Strupp B.J. Prenatal cocaine exposure increases sensitivity to the attentional effects of the dopamine D1 agonist SKF81297. Journal of Neuroscience 20 (2000) 8902-8908
9. Belluscio L., Gold G.H., Nemes A., and Axel R. Mice deficient in G(olf) are anosmic. Neuron 20 (1998) 69-81
10. Beninger R.J., and Miller R. Dopamine D1-like receptors and reward-related incentive learning. Neuroscience and Biobehavioral Reviews 22 (1998) 335-345
11. Berrettini W.H. Susceptibility loci for bipolar disorder: overlap with inherited vulnerability to schizophrenia. Biological Psychiatry 47 (2000) 245-251
12. Berrettini W.H., Vuoristo J., Ferraro T.N., Buono R.J., Wildenauer D., and Ala-Kokko L. Human G(olf) gene polymorphisms and vulnerability to bipolar disorder. Psychiatric Genetics 8 (1998) 235-238
13. Bobb A.J., Addington A.M., Sidransky E., Gornick M.C., Lerch J.P., Greenstein D.K., et al. Support for association between ADHD and two candidate genes: NET1 and DRD1. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics 134 (2005) 67-72
14. Corradi J.P., Ravyn V., Robbins A.K., Hagan K.W., Peters M.F., Bostwick R., et al. Alternative transcripts and evidence of imprinting of GNAL on 18p11.2. Molecular Psychiatry 10 (2005) 1017-1025
15. Corvol J.C., Studler J.M., Schonn J.S., Girault J.A., and Herve D. Galpha(olf) is necessary for coupling D1 and A2a receptors to adenylyl cyclase in the striatum. Journal of Neurochemistry 76 (2001) 1585-1588
16. Corvol J.C., Muriel M.P., Valjent E., Feger J., Hanoun N., Girault J.A., et al. Persistent increase in olfactory type G-protein alpha subunit levels may underlie D1 receptor functional hypersensitivity in Parkinson disease. Journal of Neuroscience 24 (2004) 7007-7014
17. Davids E., Zhang K., Tarazi F.I., and Baldessarini R.J. Animal models of attention-deficit hyperactivity disorder. Brain Research Brain Research Reviews 42 (2003) 1-21
18. Diaz Heijtz R., Scott L., and Forssberg H. Alteration of dopamine D1 receptor-mediated motor inhibition and stimulation during development in rats is associated with distinct patterns of c-fos mRNA expression in the frontal-striatal circuitry. European Journal of Neuroscience 19 (2004) 945-956
19. Dreher J.K., and Jackson D.M. Role of D1 and D2 dopamine receptors in mediating locomotor activity elicited from the nucleus accumbens of rats. Brain Research 487 (1989) 267-277
20. Dudbridge F. Pedigree disequilibrium tests for multilocus haplotypes. Genetic Epidemiology 25 (2003) 115-121
21. Durston S. A review of the biological bases of ADHD: what have we learned from imaging studies?. Mental Retardation and Developmental Disabilities Research Reviews 9 (2003) 184-195
22. Gershon E.S., Badner J.A., Detera-Wadleigh S.D., Ferraro T.N., and Berrettini W.H. Maternal inheritance and chromosome 18 allele sharing in unilineal bipolar illness pedigrees. American Journal of Medical Genetics 67 (1996) 202-207
23. Goldman-Rakic P.S., Muly III E.C., and Williams G.V. D(1) receptors in prefrontal cells and circuits. Brain Research Brain Research Reviews 31 (2000) 295-301
24. Granon S., Passetti F., Thomas K.L., Dalley J.W., Everitt B.J., and Robbins T.W. Enhanced and impaired attentional performance after infusion of D1 dopaminergic receptor agents into rat prefrontal cortex. Journal of Neuroscience 20 (2000) 1208-1215
25. Herve D., Levi-Strauss M., Marey-Semper I., Verney C., Tassin J.P., Glowinski J., et al. G(olf) and Gs in rat basal ganglia: possible involvement of G(olf) in the coupling of dopamine D1 receptor with adenylyl cyclase. Journal of Neuroscience 13 (1993) 2237-2248
26. Herve D., Le Moine C., Corvol J.C., Belluscio L., Ledent C., Fienberg A.A., et al. Galpha(olf) levels are regulated by receptor usage and control dopamine and adenosine action in the striatum. Journal of Neuroscience 21 (2001) 4390-4399
27. Horvath S., Xu X., and Laird N.M. The family based association test method: strategies for studying general genotype-phenotype associations. European Journal of Human Genetics 9 (2001) 301-306
28. Ickowicz A., Schachar R., Sugarman R., Chen S., Millette C., and Cook L. The parent interview for child symptoms (PICS): a situation-specific clinical-research interview for attention deficit hyperactivity and related disorders. Canadian Journal of Psychiatry 50 (2006) 325-328
29. Iwamoto T., Iwatsubo K., Okumura S., Hashimoto Y., Tsunematsu T., Toya Y., et al. Disruption of type 5 adenylyl cyclase negates the developmental increase in Galphaolf expression in the striatum. FEBS Letters 564 (2004) 153-156
30. Kirley A., Hawi Z., Daly G., McCarron M., Mullins C., Millar N., et al. Dopaminergic system genes in ADHD: toward a biological hypothesis. Neuropsychopharmacology 27 (2002) 607-619
31. Laurin N., Misener V.L., Crosbie J., Ickowicz A., Pathare T., Roberts W., et al. Association of the Calcyon Gene (DRD1IP) with attention deficit/hyperactive disorder. Molecular Psychiatry 10 (2005) 1117-1125
32. Levy F., Hay D.A., McStephen M., Wood C., and Waldman I. Attention-deficit hyperactivity disorder: a category or a continuum? Genetic analysis of a large-scale twin study. Journal of the American Academy of Child and Adolescent Psychiatry 36 (1997) 737-744
33. Lewis C.M., Levinson D.F., Wise L.H., DeLisi L.E., Straub R.E., Hovatta I., et al. Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia. American Journal of Human Genetics 73 (2003) 34-48
34. Lezcano N., Mrzljak L., Eubanks S., Levenson R., Goldman-Rakic P., and Bergson C. Dual signaling regulated by calcyon, a D1 dopamine receptor interacting protein. Science 287 (2000) 1660-1664
35. Lijffijt M., Kenemans J.L., Verbaten M.N., and van Engeland H. A meta-analytic review of stopping performance in attention-deficit/hyperactivity disorder: deficient inhibitory motor control?. Journal of Abnormal Psychology 114 (2005) 216-222
36. Livak K.J. Allelic discrimination using fluorogenic probes and the 5′ nuclease assay. Genetic Analysis 14 (1999) 143-149
37. Lowe N., Kirley A., Hawi Z., Sham P., Wickham H., Kratochvil C.J., et al. Joint analysis of the DRD5 marker concludes association with attention-deficit/hyperactivity disorder confined to the predominantly inattentive and combined subtypes. American Journal of Human Genetics 74 (2004) 348-356
38. Luman M., Oosterlaan J., and Sergeant J.A. The impact of reinforcement contingencies on AD/HD: a review and theoretical appraisal. Clinical Psychology Review 25 (2005) 183-213
39. Martinussen R., Hayden J., Hogg-Johnson S., and Tannock R. A meta-analysis of working memory impairments in children with attention-deficit/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry 44 (2005) 377-384
40. Meyer M.E. Effects of intraaccumbens dopamine agonist SK&F38393 and antagonist SCH23390 on locomotor activities in rats. Pharmacology Biochemistry and Behavior 45 (1993) 843-847
41. Miller S.A., Dykes D.D., and Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Research 16 (1988) 1215
42. Misener V., Luca P., Azeke O., Crosbie J., Waldman I., Tannock R., et al. Linkage of the dopamine receptor D1 gene to attention-deficit/hyperactivity disorder. Molecular Psychiatry 9 (2004) 500-509
43. Nothen M.M., Cichon S., Rohleder H., Hemmer S., Franzek E., Fritze J., et al. Evaluation of linkage of bipolar affective disorder to chromosome 18 in a sample of 57 German families. Molecular Psychiatry 4 (1999) 76-84
44. Petronis A. The genes for major psychosis: aberrant sequence or regulation?. Neuropsychopharmacology 23 (2000) 1-12
45. Quist J.F., Barr C.L., Schachar R., Roberts W., Malone M., Tannock R., et al. Evidence for the serotonin HTR2A receptor gene as a susceptibility factor in attention deficit hyperactivity disorder (ADHD). Molecular Psychiatry 5 (2000) 537-541
46. Rius R.A., Mollner S., Pfeuffer T., and Loh Y.P. Developmental changes in Gs and G(olf) proteins and adenylyl cyclases in mouse brain membranes. Brain Research 643 (1994) 50-58
47. Schwab S.G., Hallmayer J., Lerer B., Albus M., Borrmann M., Honig S., et al. Support for a chromosome 18p locus conferring susceptibility to functional psychoses in families with schizophrenia, by association and linkage analysis. American Journal of Human Genetics 63 (1998) 1139-1152
48. Schwab S.G., Hallmayer J., Albus M., Lerer B., Eckstein G.N., Borrmann M., et al. A genome-wide autosomal screen for schizophrenia susceptibility loci in 71 families with affected siblings: support for loci on chromosome 10p and 6. Molecular Psychiatry 5 (2000) 638-649
49. Schwindinger W.F., Betz K.S., Giger K.E., Sabol A., Bronson S.K., and Robishaw J.D. Loss of G protein gamma 7 alters behavior and reduces striatal alpha(olf) level and cAMP production. Journal of Biological Chemistry 278 (2003) 6575-6579
50. Seeman P., and Madras B.K. Anti-hyperactivity medication: methylphenidate and amphetamine. Molecular Psychiatry 3 (1998) 386-396
51. Segurado R., Detera-Wadleigh S.D., Levinson D.F., Lewis C.M., Gill M., Nurnberger Jr. J.I., et al. Genome scan meta-analysis of schizophrenia and bipolar disorder, part III: bipolar disorder. American Journal of Human Genetics 73 (2003) 49-62
52. Spielman R.S., and Ewens W.J. The TDT and other family-based tests for linkage disequilibrium and association. American Journal of Human Genetics 59 (1996) 983-989
53. Stine O.C., Xu J., Koskela R., McMahon F.J., Gschwend M., Friddle C., et al. Evidence for linkage of bipolar disorder to chromosome 18 with a parent-of-origin effect. American Journal of Human Genetics 57 (1995) 1384-1394
54. Tannock R, Hum M, Masellis M, Humphries T, Schachar R. Teacher telephone interview for children's academic performance, attention, behavior and learning: DSM-IV Version (TTI-IV). The Hospital for Sick Children, Toronto, Canada, Unpublished Document, 2002.
55. Thapar A., O'Donovan M., and Owen M.J. The genetics of attention deficit hyperactivity disorder. Human Molecular Genetics 14 Spec No. 2 (2005) R275-R282
56. Tsiouris S.J., Breschel T.S., Xu J., McInnis M.G., and McMahon F.J. Linkage disequilibrium analysis of G-olf alpha (GNAL) in bipolar affective disorder. American Journal of Medical Genetics 67 (1996) 491-494
57. Turecki G., Alda M., Grof P., Martin R., Cavazzoni P.A., Duffy A., et al. No association between chromosome-18 markers and lithium-responsive affective disorders. Psychiatry Research 63 (1996) 17-23
58. Undie A.S., and Friedman E. Stimulation of a dopamine D1 receptor enhances inositol phosphates formation in rat brain. Journal of Pharmacology and Experimental Therapeutics 253 (1990) 987-992
59. Van Broeckhoven C., and Verheyen G. Chromosome 18 workshop. Psychiatric Genetics 8 (1998) 97-108
60. Van Broeckhoven C., and Verheyen G. Report of the chromosome 18 workshop. Amercian Journal of Medical Genetics 88 (1999) 263-270
61. Viggiano D., Ruocco L.A., and Sadile A.G. Dopamine phenotype and behaviour in animal models: in relation to attention deficit hyperactivity disorder. Neuroscience and Biobehavioral Reviews 27 (2003) 623-637
62. Vuoristo J.T., Berrettini W.H., Overhauser J., Prockop D.J., Ferraro T.N., and Ala-Kokko L. Sequence and genomic organization of the human G-protein Golfalpha gene (GNAL) on chromosome 18p11, a susceptibility region for bipolar disorder and schizophrenia. Molecular Psychiatry 5 (2000) 495-501
63. Wang H.Y., Undie A.S., and Friedman E. Evidence for the coupling of Gq protein to D1-like dopamine sites in rat striatum: possible role in dopamine-mediated inositol phosphate formation. Molecular Pharmacology 48 (1995) 988-994
64. Willcutt E.G., Pennington B.F., Olson R.K., Chhabildas N., and Hulslander J. Neuropsychological analyses of comorbidity between reading disability and attention deficit hyperactivity disorder: in search of the common deficit. Developmental Neuropsychology 27 (2005) 35-78
65. Williams G.V., and Castner S.A. Under the curve: critical issues for elucidating D1 receptor function in working memory. Neuroscience 139 (2006) 263-276
66. Xu M., Hu X.T., Cooper D.C., Moratalla R., Graybiel A.M., White F.J., et al. Elimination of cocaine-induced hyperactivity and dopamine-mediated neurophysiological effects in dopamine D1 receptor mutant mice. Cell 79 (1994) 945-955
67. Xu M., Moratalla R., Gold L.H., Hiroi N., Koob G.F., Graybiel A.M., et al. Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses. Cell 79 (1994) 729-742
68. Zhuang X., Belluscio L., and Hen R. G(olf)alpha mediates dopamine D1 receptor signaling. Journal of Neuroscience 20 (2000) RC91
69. Zill P., Engel R., Baghai T.C., Zwanzger P., Schule C., Minov C., et al. Analysis of polymorphisms in the olfactory G-protein Golf in major depression. Psychiatric Genetics 12 (2002) 17-22
70. Zill P., Malitas P.N., Bondy B., Engel R., Boufidou F., Behrens S., et al. Analysis of polymorphisms in the alpha-subunit of the olfactory G-protein Golf in lithium-treated bipolar patients. Psychiatric Genetics 13 (2003) 65-69